NEXOBRID

Vericel Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 3, 2023
Approval ID: 1a2f23ad-78ef-43fa-9864-6bd77aac9e57
Products: 0 registered
Version: 5

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"content": {"@styleCode": "bold", "br": [null, null, null], "sup": "®", "#text": "These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID.\n NEXOBRID (anacaulase-bcdb), for topical gelInitial U.S. Approval: 2022"}}

Quick Stats

Total Products0

Labelers1

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.